Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive

  • staffstaff
  • AI
  • March 31, 2025
  • 0 Comments

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised external capital for the first time. The $600 million round was led by Thrive Capital, with participation from GV and existing investor Alphabet, Google’s parent, it said.     The funding will accelerate further development of Isomorphic’s AI drug […]

  • Related Posts

    Midjourney releases its first new AI image model in nearly a year

    Midjourney, one of the earliest AI image-generating services on the web, has released its first new AI image model in nearly a year. Dubbed V7, the model, which began rolling…

    Continue reading
    Amazon’s new AI agent will shop third-party sites for you

    Amazon is starting to test a new AI shopping agent, a feature it calls “Buy for Me,” with a subset users, the company announced in a blog post Thursday. If…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Midjourney releases its first new AI image model in nearly a year

    • By staff
    • April 4, 2025
    • 1 views

    Amazon’s new AI agent will shop third-party sites for you

    • By staff
    • April 4, 2025
    • 1 views

    OpenAI just made its first cybersecurity investment 

    • By staff
    • April 3, 2025
    • 2 views

    Teen with 4.0 GPA who built the viral Cal AI app was rejected by 15 top universities

    • By staff
    • April 3, 2025
    • 2 views